Can I discontinue hydroxyzine for anxiety?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Discontinuing Hydroxyzine for Anxiety

Yes, hydroxyzine can be safely discontinued abruptly without a taper, as it does not cause physical dependence or withdrawal symptoms, and discontinuation does not produce rebound anxiety. 1, 2

Evidence Supporting Safe Discontinuation

No Withdrawal or Rebound Phenomena

  • Abrupt discontinuation is safe: Clinical trials demonstrate that hydroxyzine can be stopped immediately after 4 weeks of treatment without producing withdrawal symptoms or rebound anxiety. 2
  • No dependency risk: Unlike benzodiazepines, hydroxyzine does not cause physical dependence even with prolonged use, making it fundamentally different from other anxiolytics in this regard. 3
  • Maintained benefit after stopping: In controlled studies, the anxiolytic effect of hydroxyzine persisted for at least one week after abrupt discontinuation, with no emergence of withdrawal symptoms. 2

Comparison to Benzodiazepine Withdrawal

  • Hydroxyzine as a withdrawal aid: Hydroxyzine has actually been studied as a support medication to help patients withdraw from long-term benzodiazepine use, demonstrating its lack of dependency potential. 4
  • Effective in lorazepam withdrawal: In a study of 154 patients withdrawing from chronic lorazepam use, hydroxyzine (both 25 mg and 50 mg daily) significantly improved anxiety levels and reduced withdrawal symptoms compared to placebo, with no evidence of creating its own withdrawal syndrome. 4

Clinical Context and Limitations

Efficacy Considerations

  • Modest evidence base: While hydroxyzine shows superiority over placebo for generalized anxiety disorder (OR 0.30,95% CI 0.15 to 0.58), the overall quality of evidence is limited by high risk of bias in available studies and small sample sizes. 5
  • Not a first-line agent: Due to the limited evidence base and availability of more robustly studied alternatives (SSRIs, SNRIs, CBT), hydroxyzine is not recommended as a reliable first-line treatment for GAD. 5

Safety Profile to Monitor

  • QT prolongation risk: Hydroxyzine carries a risk of QT prolongation and Torsade de Pointes, particularly in patients with pre-existing cardiac risk factors, electrolyte imbalances, or concurrent use of other QT-prolonging medications. 1
  • CNS depression: The most common adverse effect is drowsiness (28% vs 14% with placebo), which typically appears during the first week and progressively diminishes with continued use. 2
  • Driving impairment: Hydroxyzine can significantly impair psychomotor function and driving ability, with documented cases of impaired driving even at therapeutic doses. 6
  • Rare serious reactions: Acute generalized exanthematous pustulosis (AGEP) is a rare but serious skin reaction requiring immediate discontinuation if any rash or skin reaction develops. 1

Practical Discontinuation Protocol

How to Stop

  • Simply stop taking it: No taper is required; discontinue the medication on the day you decide to stop. 2
  • Timing consideration: If hydroxyzine was being used primarily for sleep, consider stopping it on a night when poor sleep the following night would be less disruptive (e.g., Friday evening). 7

What to Expect After Stopping

  • No withdrawal symptoms: You should not experience dizziness, nausea, rebound anxiety, or other discontinuation phenomena that occur with SSRIs or benzodiazepines. 2
  • Possible return of original symptoms: The underlying anxiety that hydroxyzine was treating may return, but this represents the natural course of the condition rather than a withdrawal effect. 2

Transitioning to Alternative Treatment

  • Consider evidence-based alternatives: If ongoing anxiety treatment is needed, SSRIs (escitalopram, sertraline) or SNRIs (duloxetine, venlafaxine) have stronger evidence for GAD and are recommended as first-line pharmacotherapy. 8
  • Cognitive behavioral therapy: CBT specifically designed for anxiety disorders (approximately 14 sessions over 4 months) is an effective alternative or adjunct to pharmacotherapy. 8
  • Direct switch if needed: If transitioning to an SSRI or SNRI, hydroxyzine can be stopped on the same day the new medication is started, as there is no risk of drug interaction or need for washout. 9

Common Pitfalls to Avoid

  • Do not confuse with SSRI discontinuation: Unlike SSRIs (particularly paroxetine, sertraline, and fluvoxamine), which require gradual tapers to avoid discontinuation syndrome, hydroxyzine does not require this precaution. 10
  • Do not assume all anxiolytics are the same: Benzodiazepines require careful tapering due to physical dependence; hydroxyzine does not share this property. 4
  • Do not restart without addressing underlying anxiety: If anxiety symptoms return after discontinuation, this indicates the need for a more definitive treatment approach rather than simply resuming hydroxyzine. 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.